Syuzo Kaneko, Ken Takasawa, Ken Asada, Kouya Shiraishi, Noriko Ikawa, Hidenori Machino, Norio Shinkai, Maiko Matsuda, Mari Masuda, Shungo Adachi, et al. Mechanism of ERBB2 gene overexpression by the formation of super-enhancer with genomic structural abnormalities in lung adenocarcinoma without clinically actionable genetic alterations. Molecular Cancer. 2024. 23. 1
Amina Bolatkan, Ken Asada, Syuzo Kaneko, Masaaki Komatsu, Ryuji Hamamoto. Abstract 1712: Identifying a novel alternative promoter usage in HDAC9: Implications for LUAD prognosis and therapy. Cancer Research. 2024. 84. 6_Supplement. 1712-1712
Ken Takasawa, Ken Asada, Syuzo Kaneko, Kouya Shiraishi, Hidenori Machino, Satoshi Takahashi, Norio Shinkai, Nobuji Kouno, Kazuma Kobayashi, Masaaki Komatsu, et al. Advances in cancer DNA methylation analysis with methPLIER: use of non-negative matrix factorization and knowledge-based constraints to enhance biological interpretability. Experimental & Molecular Medicine. 2024
Hidenori Machino, Ai Dozen, Mariko Konaka, Masaaki Komatsu, Kohei Nakamura, Noriko Ikawa, Kanto Shozu, Ken Asada, Syuzo Kaneko, Hiroshi Yoshida, et al. Integrative analysis reveals early epigenetic alterations in high-grade serous ovarian carcinomas. Experimental & molecular medicine. 2023
Ryuji Hamamoto, Ken Takasawa, Norio Shinkai, Hidenori Machino, Nobuji Kouno, Ken Asada, Masaaki Komatsu, Syuzo Kaneko. Analysis of super-enhancer using machine learning and its application to medical biology. Briefings in bioinformatics. 2023
新海 典夫, 金子 修三, 浅田 健, 高澤 建, 小松 正明, 浜本 隆二. 公開ChIP-seq及びRNA-seq情報から得たTF及び遺伝子発現情報を用いたがん関連スーパーエンハンサー評価システム(Cancer-related super-enhancer evaluation system using TFs and gene expression data from public ChIP-seq and RNA-seq data). 日本癌学会総会記事. 2022. 81回. P-1107